Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
09/2005
09/21/2005EP1575990A2 Methods, compositions and libraries pertaining pna dimer and pna oligomer synthesis
09/21/2005EP1575988A2 Short peptides from the '2nd loop' of 7 transmembrane receptor which selectively modulate signal transduction
09/21/2005EP1575987A2 Conjugates of membrane translocating agents and pharmaceutically active agents
09/21/2005EP1575986A2 Peptides and methods for cell death regulation
09/21/2005EP1575984A2 Identification and cloning of a novel human gene, ret16, involved in the intracellular signaling cascade
09/21/2005EP1575979A2 West nile virus vaccine
09/21/2005EP1575967A2 Process for the extraction and isolation of insulin from recombinant sources
09/21/2005EP1575917A2 Hemipteran muscarinic receptor
09/21/2005EP1575867A2 Peptide nanostructures and methods of generating and using the same
09/21/2005EP1575658A2 Screening and therapeutic methods for treating circadian rhythm disorders
09/21/2005EP1575614A1 Recombinant proteins of parapoxvirus ovis and pharmaceutical compositions therefrom
09/21/2005EP1575611A2 Modified vaccinia ankara expressing p53 in cancer immunotherapy
09/21/2005EP1575610A1 Live attenuated vaccine against porcine pleuropneumonia
09/21/2005EP1575609A2 Methods for treating viral infection using il-28 and il-29
09/21/2005EP1575607A1 Vanilloid receptor-2 ligands for treating anxiety or depression
09/21/2005EP1575602A2 Methods for treating cancer using porimin as a target
09/21/2005EP1575529A2 Peptides and methods of screening immunogenic peptide vaccines against alzheimer's disease
09/21/2005EP1575528A2 Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs
09/21/2005EP1575525A2 Cell surface tropomyosin as a target of angiogenesis inhibition
09/21/2005EP1575524A2 Proliferated cell lines and uses thereof
09/21/2005EP1575517A2 Anti-ngf antibodies and methods using same
09/21/2005EP1575515A2 Achaete-scute like-2 polypeptides and encoding nucleic acids and methods for the diagnosis and treatment of tumor
09/21/2005EP1575512A2 Methods and compositions for prostate epithelial cell differentiation
09/21/2005EP1575511A2 A new target for angiogenesis and anti-angiogenesis therapy
09/21/2005EP1575505A2 Codon-optimized polynucleotide-based vaccines against bacillus anthracis infection
09/21/2005EP1575500A2 Mesothelin vaccines and model systems
09/21/2005EP1575497A2 Novel composition and methods for the treatment of psoriasis
09/21/2005EP1575490A2 Modified glucagon-like peptide-1 analogs
09/21/2005EP1575485A2 Methods for lightening skin and hair
09/21/2005EP1575483A2 Attenuated gram negative bacteria
09/21/2005EP1575480A2 Compositions and methods for the treatment of immune related diseases
09/21/2005EP1575479A2 Hsp peptides and analogs for modulation of immune responses via antigen presenting cells
09/21/2005EP1575477A2 HIGH AFFINITY LIGAND FOR p75 NEUROTROPHIN RECEPTOR
09/21/2005EP1575419A2 Forming iron nitrosyl hemoglobin
09/21/2005EP1575354A1 Melusin, a muscle specific protein, as a drug target for prevention and treatment of heart failure
09/21/2005EP1478923A4 Assay for anti-ingap antibodies
09/21/2005EP1404377B1 Improved chelator conjugates
09/21/2005EP1373546A4 Carrier chimeric proteins, targeted carrier chimeric proteins and preparation thereof
09/21/2005EP1294877B1 Cgi-69 compositions and methods of use
09/21/2005EP1212082A4 Monoclonal antibodies and antibody cocktail for detection of prion protein as an indication of transmissible spongiform encephalopathies
09/21/2005EP1192256B1 Global regulators of bacterial pathogenic genes; bacterial autoinducer inactivation protein, as targets for engineering disease resistance
09/21/2005EP1191037B1 Means of stabilizing hemoglobins
09/21/2005EP1094081B1 Fused protein with direct bond of il-6-receptor to il-6
09/21/2005EP1061805B1 Regulation of endogenous gene expression in cells using zinc finger proteins
09/21/2005EP1027371B1 Process for the production of highly viral safe thrombin for forming fibrin glue from a pool of human plasma
09/21/2005EP0996459B1 Use of exendins and agonists thereof for the reduction of food intake
09/21/2005EP0974057B1 Methods to detect hk2 polypeptides
09/21/2005EP0961836B1 Dna encoding canine von willebrand factor and methods of use
09/21/2005EP0846171B1 Chromosome 1 gene and gene products related to alzheimer's disease
09/21/2005EP0804565B1 Tetracycline-regulated transcriptional modulators
09/21/2005EP0793721B1 Peptides capable of binding to the gap protein sh3 domain, nucleotide sequences coding therefor, and preparation and use thereof
09/21/2005EP0792364B1 Lgmd gene coding for a calcium dependent protease
09/21/2005EP0776337B1 Growth differentiation factor-11
09/21/2005EP0752853B1 Human brain phosphodiesterase
09/21/2005CN1672055A Heterologous stimulus-gated ion channels and methods of using same
09/21/2005CN1671845A Immunogenic sequences
09/21/2005CN1671844A Antigenic neisserial peptides
09/21/2005CN1671843A Factor participating in transcriptional regulation
09/21/2005CN1671742A Use of HMGB1 in the treatment of tissue damage and/or to promote tissue repair
09/21/2005CN1671739A Corn root preferential promoters and uses thereof
09/21/2005CN1671738A The bZIP type transcription factor of corn and its coding gene and the usage thereof
09/21/2005CN1671737A Export and modification of (poly)peptides in the lantibiotic way
09/21/2005CN1671736A Pegylated T20 polypeptide
09/21/2005CN1671735A Pegylated T1249 polypeptide
09/21/2005CN1671734A CFTR modifier genes and expressed polypeptides useful in treating cystic fibrosis and methods and products for detecting and/or identifying same
09/21/2005CN1671733A Compositions and methods for WT1 specific immunotherapy
09/21/2005CN1671722A Campylobacter glycans and glycopeptides
09/21/2005CN1671423A Novel chimeric CD154
09/21/2005CN1671420A Pegylated factor VII glycoforms
09/21/2005CN1671413A Vaccine composition comprising transferrin bindin derived from gram-negative bacteria and HSF
09/21/2005CN1670213A Glyt1 transgenic mouse
09/21/2005CN1670208A Cancer-inhibiting gene and its application in preparing anticancer medicine combined with chemical therapeutic medicine
09/21/2005CN1670035A Endothelium chalone capable of improving antitumor activity with changed structure and its use
09/21/2005CN1670034A Method for producing Pichia anomala expression recombination human interleukin 11
09/21/2005CN1670033A Method for preparing human interleukin 29 and recombinant IL-29 engineering strain
09/21/2005CN1670032A Human telomerase active inhibitor protein and use thereof
09/21/2005CN1670031A Method for separating human plasma protein fraction by press filtration process
09/21/2005CN1219882C Method and combination for treating tumors based on ERBB-3
09/21/2005CN1219881C Human protooncogene and protein encoded therein
09/21/2005CN1219811C Protein finishing agent with long tail of methoxy carbowax as well as preparation method and application
09/21/2005CN1219796C Application of N-end amino acid of interferon-tau polypeptide
09/21/2005CN1219795C Renaturation process for preparing human recombinant nerve growth factor
09/20/2005US6947845 Method of identifying molecules that bind to the large ribosomal subunit
09/20/2005US6947844 Modulators of ribosomal function and identification thereof
09/20/2005US6946589 Compositions and methods for altering amino acid content of proteins
09/20/2005US6946587 DNA-coated microprojectile bombardment of friable embryogenic callus, selection and plant regeneration; herbicide, insect and antibiotic resistance;
09/20/2005US6946548 Granulocyte colony stimulating factor ("G-CSF") analog polypeptide compositions, related nucleic acids, expression constructs, host cells, and processes for recombinant production of the present G-CSF analogs.
09/20/2005US6946544 XAF genes and polypeptides: methods and reagents for modulating apoptosis
09/20/2005US6946543 Truncated EGF receptor
09/20/2005US6946445 peptide antagonists of CXC chemokine receptor 4, CXCR4; cancer and autoimmune diseases; protein that comprises an N-terminal sequence of KGVSLSYR (SEQ ID NO: 3); stromal cell derived factor one (SDF-1 ligand
09/20/2005US6946444 Modify the activity of the lipolysis stimulated receptor and can be used to influence the partitioning of dietary lipids between the liver and peripheral tissues; treating obesity-related insulin resistance
09/20/2005US6946439 Angiogenesis inhibitors; antitumor agents
09/20/2005US6946296 Methods and compositions for polypeptide engineering
09/20/2005US6946294 Transgenic plant transformed with a translationally controlled tumor protein (TCTP) gene
09/20/2005US6946289 Single-stranded polynucleotides that code for human melanoma antigen(MAGE) and human leukocyte antigens, used in gene therapy and medical diagnosis; immunology
09/20/2005US6946281 N-acetylglucosamine 2-epimerase and DNA encoding the same
09/20/2005US6946279 Thrombin derivatives and process for producing the same, anhydrothrombin derivatives and process for producing the same, platelet agglutination-inducing compositions, method of inducing platelet agglutination, clinical test reagents, clinical test method, thrombosis inhibitors, adsorbent and process for producing the same
09/20/2005US6946278 Serine proteases inhibitors comprising chymostrypsin site from transgenic plants; insect resistance
09/20/2005US6946265 Genetic engineered polypeptides having replacements in the amino acid sequences, used as for prophylaxis of growth disorders such as turner's syndrome, muscular dystrophy, congestive heart failure, bone and metabolic disorders; stability
09/20/2005US6946264 DNA codes for polypeptides having amino acid sequences used as metalloenzyme inhibitors, for prophylaxis of autoimmune diseases or as wound healing agents
1 ... 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 1163 1164 1165 1166 1167 1168 1169 1170 1171 1172 1173 ... 2916